Schedule 13D ownership disclosure

HEMISPHERX BIOPHARMA INC

Security class unavailable · CUSIP: 42366C301

Event date: 2018-10-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-19-005045
Form type
SC 13D
Filer
Equels Thomas K
CIK
CIK 1450324
Filed
Apr 09, 2019
Reporting period
Oct 17, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub